Experts Report Moderate Patient Adherence to Melanoma Screening and Surveillance Program
Source: Dermatology Times, August 2024
Researchers tailored screening and surveillance schedules to individual risk of patients.
The implementation of a melanoma screening and surveillance program tailored to individual patient needs yielded a 62%, or moderate, level of adherence, according to a study published in the International Journal of Cancer.1
Researchers found that decisions to deviate from adherence were more frequently influenced by clinicians than by patients.
